Boston's Whittier Street Health Center Announces New Medical Director

Dr. Shilpa Malhotra has joined the historic Boston community health care center as Medical Director in 2020
Press Release – updated: Jan 17, 2020 09:00 EST

ROXBURY, Mass., January 17, 2020 ( – Whittier Street Health Center is thrilled to announce that Dr. Shilpa Malhotra, MD, MHSA, has joined its family in 2020 and will serve as the health care center’s Medical Director for primary care.
“I am very pleased to announce the appointment of Dr. Malhotra as Medical Director at Whittier. Dr. Malhotra is an excellent physician and proven leader who is dedicated to fulfilling our vision and serving our community,” said Frederica Williams, President and CEO of Whittier Street Health Center.
Dr. Malhotra brings with her a specialized clinical experience, which includes a focus on gynecology, menopause management, and family planning. Dr. Malhotra is a graduate of The George Washington University and completed an Obstetrics and Gynecology residency training program at Long Island Jewish Hospital in New York. 
Prior to accepting the position at Whittier, Dr. Malhotra served as an attending physician in OB/GYN at Atrius Healthcare in Burlington, Massachusetts, as an attending physician at Advanced Care for Women in Reading, Pennsylvania, and Contemporary Women’s Care in Southside, New York. Her clinical interests include Women’s Health and Preventative Health care. She speaks English, Hindi, and Marathi
“I look forward to working closely with all the outstanding and talented physicians and colleagues at Whittier in this new role,” says Dr. Malhotra. “Whittier is a leader in comprehensive care and has a long-standing commitment to serving the health care needs of Boston’s underserved communities. I am inspired and excited to continue and expand Whittier’s excellence in patient care and our program growth.”
As Whittier’s Medical Director, Dr. Malhotra will advise and lead the clinical staff towards fulfilling Whittier’s mission to be the premier leader in urban health care. This includes an aggressive rollout of new services at the health care center in 2020, including a new Weight Management and Related Diseases Clinic, and Whittier’s Boston Health Equity program, which is an innovative population health management system to address social inequities and health disparities. 
The mission of Whittier Street Health Center is to provide high-quality, reliable and accessible primary health care and support services for diverse populations to promote wellness and eliminate health and social disparities. The health center also provides an on-site clinical partnership with Dana Farber Cancer Institute; dentistry; HIV services; laboratory; OB/GYN; pediatrics; eye care; mental health, and 40 social service initiatives. WSHC is a 501c3 charitable organization.
Media Contact:Jesse Migneault​Phone: 617.989.3283Email:
Source: Whittier Street Health Center

Multi-Location Medical Plaza Selects Updox Collaboration Platform for Digital Marketing, Communications and Patient Engagement

Next-Generation Updox Platform Helps Medical Plaza Pharmacy Acquire Customers, Engage Patients and Collaborate with Providers(PRWeb January 16, 2020)Read the full story at

Governor Tom Wolf Visits Sheba Medical Center to Deepen Collaboration Between Israel’s Leading Hospital and the State of Pennsylvania

Governor Wolf visited Sheba Medical Center to view Sheba’s ARC Innovation Center, an innovative epicenter for researchers and startups working to solve global healthcare challenges. Sheba’s ARC Innovation Center is already collaborating with Thomas Jefferson University in Philadelphia to bring life saving medical solutions to the United States.(PRWeb January 15, 2020)Read the full story at

Governor Pritzker Receives FDA Testimonies on Non-Exempt Medical Device as FDA Delays to Not Inform the Patients Across the United States as Confirmed by Dr. Rajamannan at Most Sacred Heart of Jesus Cardiology and Valvular Institute

FDA confirms no plan to inform patients of non-exempt medical devices placed in 667 citizens across the United States
Press Release – updated: Jan 15, 2020 16:00 EST

SPRINGFIELD, Ill., January 15, 2020 ( – Most Sacred Heart of Jesus Cardiology and Valvular Institute Medical Director Dr. Nalini Rajamannan has sent an FDA Affidavit outlining Chicagoans testimonies to Governor Pritzker following recent reporting by Kaiser Health News that the FDA has lifted their exemption laws.​​ Dr. Nalini Rajamannan, a specialist for patients with valvular heart disease in Most Sacred Heart of Jesus Cardiology, confirms FDA statements after a decade of requesting answers from the FDA from her location in Downtown Sheboygan. Dr. Rajamannan revealed the confirmation FDA letter to Congressman Glenn Grothman that the Food and Drug Deputy Commissioner on policy for the FDA will not inform the patients regarding the status of a heart device implanted in 667 patients across the United States of America.
Former Board of Trustee for the University and now Governor of Illinois, Gov. Pritzker receives the FDA affidavit after years of delays by the FDA in reporting to the patients. The surgical placement for these devices began in 2006. In 2007, the device manufacturer confirmed the “exempt status” in a two-line email to the hospital. The saga related to the heart device is outlined by Dr. Elisabeth Rosenthal’s new book “An American Sickness” highlights the issues related to exempt medical devices in the chapter, “How to get into a Patient’s Heart? Follow the Money.” The chapter outlines the events summarized by eye-witness Dr. Nalini M. Rajamannan in the series “The Myxo Files a XXIV: A Tale of Three Rings” as published by Kindle Publishing on Dr. Rajamannan reviewed the FDA letter to the Senate Finance Committee’s Chairman Grassley after several years of investigations, classifying the device as not exempt from reporting the device to the FDA, and that the device manufacturer needs to submit a new approval application. 
Summation points from the recent press conference at the Institute after a decade of FDA investigations:
1)    FDA report to Senate Finance Committee confirms the Myxo ETlogix Device is not exempt and needed an approval from the FDA.
2)    FDA letter to Senator Lugar confirms 667+ patients received the non-exempt device which needed an approval.
3)    FDA report to the House committee on Government oversight confirms that the FDA does not plan to inform the patients.
4)    Congressman Grothman is still waiting for a response as to why the FDA is not planning to inform the patients.
5)    HHS Inspector General Daniel Levinson is not planning to inform the patients of the non-exempt status of the heart device after requests for information by Senator Ron Johnson.
6)    Dr. Rajamannan Presented documents and affidavit to Senator Amy Klobuchar and Senator Durbin on behalf of then-President Obama, who have met with Dr. Rajamannan and are also involved in the investigation from the Senate Judiciary Committee and waiting for a response.
7) Awaiting Governor Pritzker’s review of FDA Affidavit.
The information will help the 667+ patients to finally may get answers about whether medical devices placed in their bodies are tested and safe, as the Food and Drug Administration begins to allow access to volumes of previously shielded data from consumers as written to then-Senator Richard Lugar (IN) and Congressman Glenn Grothman (WI). The Senate Finance committee is involved in these investigations on behalf of Medicare and Medicaid because government dollars fund the use of medical devices in patients’ health. More importantly, the new changes to the FDA reporting laws as outlined by KHN will help patients know more about medical devices implanted into their bodies.
Dr. Nalini Rajamannan is a heart valve expert in the field of cardiovascular medicine. She earned her undergraduate science pre-professional degree from the University of Notre Dame, her Medical Doctorate from Mayo Medical School and her post-graduate training in Internal Medicine and Cardiology at the Mayo Clinic and Research Fellowship on the NIH training Grant. She also worked at the Mayo Clinic as a staff consultant in Internal Medicine and an Associate Professor of Medicine at Northwestern University and the Lakeside and Westside VA. Currently, she practices consultative valvular medicine and Osteocardiology at Most Sacred Heart of Jesus Cardiology and Valvular Institute, WI.
​Press ContactOscar Delgado​​Press Officer for Most Sacred Heart of Jesus Cardiology and Valvular InstituteFormer NBC Bureau Chief Latin
Source: Most Sacred Heart of Jesus Cardiology

Greenberg Traurig’s Life Sciences & Medical Technology Group Hosts 6th Annual Deal-Making Workshop and Reception in San Francisco

SAN FRANCISCO (PRWEB) January 15, 2020
For the sixth consecutive year, Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group hosted two events coinciding with the JP Morgan Healthcare Conference in San Francisco.
On Jan. 14 the group presented the lunchtime panel discussion, “Insiders’ Views of Deal Makings,” where seasoned executives from leading life sciences companies shared current trends, best practices, and pitfalls of deals including M&A, licensing, joint ventures, and strategic collaborations. They also shared predictions on what 2020 will hold for deal making. Panelists included:
Debbie Alexander, Director, Business Development, 23andMe
Shaun Grady, Senior VP, Business Development Operations, AstraZeneca
Dr. Robert Mittendorff, Partner, Norwest Venture Partners
Jeremy Sohn, Vice President, Global Head of Digital Business Development & Licensing, Novartis
The panel was moderated by Fiona Adams, co-chair of Greenberg Traurig’s Global Corporate Practice and managing shareholder of the London office, and Wayne H. Elowe, co-chair of the firm’s global Life Sciences & Medical Technology Group and the Atlanta office Corporate Practice. David J. Dykeman, patent attorney and co-chair of the global Life Sciences & Medical Technology Group and Boston officeIntellectual Property & Technology Group, gave opening remarks.
The program was preceded by a private wine tasting and networking reception on Jan. 13, attended by more than 300 health care industry executives and investors.
In addition, Kate Black, a shareholder in the firm’s Data, Privacy & Cybersecurity Practice in the Miami office, introduced companies at the Biotech Showcase on Jan. 14.
About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: Twitter: @GT_Law.

Share article on social media or email:

Garey Orthopedic Medical Group Relocates Pomona Facility

Garey Orthopedic Medical Group is excited to announce the relocation of their Pomona clinic to a newly renovated, state-of-the-art facility at Casa Colina’s campus, located at 255 E Bonita Ave, Bldg 1, Suite 101.(PRWeb January 15, 2020)Read the full story at

Sarah Ochieng, BSN, RN, CMSRN's New Book, 'Reflections of a Medical-Surgical Nurse' is a Compelling Collection of Poems About the Life and Work of a Nurse

Recent release “Reflections of a Medical-Surgical Nurse” from Covenant Books author Sarah Ochieng, BSN, RN, CMSRN is a fascinating book that gives insight into why nurses are often called angels in human form sent from above to watch over patients.
Press Release – updated: Jan 15, 2020 06:00 EST

ARLINGTON, Texas, January 15, 2020 ( – Sarah Ochieng, BSN, RN, CMSRN, is a Certified Medical-Surgical Nurse with fifteen years of experience as a medical-surgical oncology nurse who has also worked in a skilled nursing facility and as a home health nurse. She has completed her new book, “Reflections of a Medical-Surgical Nurse; The Patient; Short Poems”: an entertaining account for readers as it touches on what is unseen through the walls of a hospital; it touches the heart of nursing.
Sarah writes, “Reflections of a Medical-Surgical Nurse is a collection of poems written by a nurse about everyday interactions with patients. ­This reflective book, though light and easy to read, offers an insight into some of the essential aspects of patients and patient care in a subtle way. A compilation of poems not only for nurses, but also a thoughtful read for all.
“Caring for patients is a privilege. They entrust their lives to clinicians during some of their most vulnerable times. Each one of them deserves excellent care. It is not a one-person mission; it takes a whole team. Patients may not always say it, but they never forget the kind of care they received.”
Published by Covenant Books of Murrells Inlet, South Carolina, Ochieng’s new book is a stirring handbook filled with poems that will give readers insight into the lives and emotions of hospital nurses and how they care for every patient.
Readers can purchase “Reflections of a Medical-Surgical Nurse” at bookstores everywhere, or online at the Apple iTunes store, Amazon, or Barnes and Noble.
Covenant Books is an international Christian owned and operated publishing house based in Murrells Inlet, South Carolina. Covenant Books specializes in all genres of work which appeal to the Christian market. For additional information or media inquiries, contact Covenant Books at 843-507-8373.
Source: Covenant Books

Modern Living with kathy ireland®: See ConTIPI Medical Introduce Their Non-Surgical Solutions for Women with Pelvic Floor Disorders

Modern Living with kathy ireland® is pleased to announce an exclusive interview with ConTIPI Medical CEO Dr. Elan Ziv to discuss their revolutionary new device for pelvic organ prolapse.(PRWeb January 14, 2020)Read the full story at